Business
Currency:JPY
2024/FY
Stock NameRevenueRatio
Regenerative medical products business1.41B55.95%
Regenerative medicine contract business865.53M34.43%
Research and development support project242.04M9.63%
Region
Currency:JPY
2024/FY
Stock NameRevenueRatio
Japan2.26B90.00%
Others251.42M10.00%